Crossref
Formation and evolution of China’s mRNA platform technology: from COVID-19 vaccines to next-generation therapeutics
SCIENTIA SINICA Vitae · 01.07.2026 · 56 (7) · 1639-1662
DOI: 10.1360/ssv-2026-0120 ↗Kurz gefasst
Fachartikel in der Zeitschrift SCIENTIA SINICA Vitae, online erschienen am 18.06.2026. Verfasst von JinZhong LIN. Die Arbeit nennt 105 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
LIN, J. (2026). Formation and evolution of China’s mRNA platform technology: from COVID-19 vaccines to next-generation therapeutics. SCIENTIA SINICA Vitae, 56(7), 1639-1662. https://doi.org/10.1360/ssv-2026-0120
Vancouver
LIN J. Formation and evolution of China’s mRNA platform technology: from COVID-19 vaccines to next-generation therapeutics. SCIENTIA SINICA Vitae. 2026;56(7):1639-1662. doi:10.1360/ssv-2026-0120
BibTeX
@article{LIN2026,
author = {LIN, JinZhong},
title = {Formation and evolution of China’s mRNA platform technology: from COVID-19 vaccines to next-generation therapeutics},
journal = {SCIENTIA SINICA Vitae},
year = {2026},
volume = {56},
number = {7},
pages = {1639--1662},
doi = {10.1360/ssv-2026-0120}
}
EUVIMED